SCHEMBL20030093

SCHEMBL20030093

C=NNc1ccc(Nc2nnc(-c3cccc(OCC(=O)NC(C)C)c3)s2)cc1C

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK1 Q13464 7/20 0.64
▸ ROCK2 O75116 8/20 0.49
▸ KDM4E B2RXH2 4/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ HSD17B10 Q99714 3/20 0.42
▸ HPGD P15428 2/20 0.42
▸ CLK2 P49760 1/20 0.41
▸ BLK P51451 1/20 0.41
▸ CSNK2A1 P68400 1/20 0.41
▸ STK3 Q13188 1/20 0.41
▸ DYRK1A Q13627 1/20 0.41
▸ AURKB Q96GD4 1/20 0.41
▸ CLK4 Q9HAZ1 1/20 0.41
▸ STK17A Q9UEE5 1/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ MAPT P10636 3/20 0.40
▸ POLB P06746 3/20 0.40
▸ HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18056386 0.78 ROCK1 (1.00) ROCK1ROCK2CLK2BLKCSNK2A1
SCHEMBL20611956 0.77 ROCK2 (0.44) ROCK1ROCK2SMN1; SMN2POLBLMNA
Trifluoroacetic Acid SCHEMBL18038124 0.74 ROCK1 (0.89) ROCK1ROCK2CLK2BLKCSNK2A1
SCHEMBL18792356 0.71 ROCK2 (0.66) ROCK1ROCK2SMN1; SMN2SLC2A1SLC2A3
SCHEMBL18792298 0.69 ROCK2 (0.68) ROCK1ROCK2SMN1; SMN2MEN1KMT2A
SCHEMBL6153628 0.69 ROCK1 (0.53) ROCK1ROCK2KDM4EALDH1A1HSD17B10
SCHEMBL18038381 0.68 ROCK1 (0.81) ROCK1ROCK2CLK2BLKCSNK2A1
SCHEMBL6154211 0.68 NOTUM (0.54) ROCK1ROCK2KDM4EALDH1A1HSD17B10
SCHEMBL18792334 0.68 ROCK2 (0.71) ROCK1ROCK2CLK2BLKCSNK2A1
SCHEMBL6153927 0.68 ALDH1A1 (0.52) ROCK1ROCK2KDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180093978-A1 INDAZOLYL THIADIAZOLAMINES AND RELATED COMPOUNDS FOR INHIBITION OF RHO-ASSOCIATED PROTEIN KINASE AND THE TREATMENT OF DISEASE WILMINGTON TRUST, NATIONAL ASSOCIATION 2018-04-05 — — US disclosed
US-9238815-B2 Compositions and methods for inhibiting human host factors required for influenza virus replication Icahn School of Medicine at Mounta Sinai (US) 2016-01-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180093978-A1 INDAZOLYL THIADIAZOLAMINES AND RELATED COMPOUNDS FOR INHIBITION OF RHO-ASSOCIATED PROTEIN KINASE AND THE TREATMENT OF DISEASE ROCK1, ROCK2, CIT ROCK1 1/4885ROCK2 2/4885KDM4E 653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback